Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

Market Cap	27.55M
Revenue (ttm)	16.21M
Net Income (ttm)	3.01M
Shares Out	9.50M
EPS (ttm)	0.31
PE Ratio	9.25
Forward PE	n/a
Dividend	0.22 (7.59%)
Ex-Dividend Date	Apr 10, 2025

Volume	190
Average Volume	1,099
Open	2.920
Previous Close	2.900
Day's Range	2.920 - 2.920
52-Week Range	2.450 - 3.150
Beta	0.12
RSI	44.84
Earnings Date	Jul 28, 2025

About VMware

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 234
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2024, ASE:HPIC's revenue was 16.71 million, an increase of 5.72% compared to the previous year's 15.81 million. Earnings were 3.09 million, an increase of 32.73%.